VETOQUINOL Corporate brochure 2007 (year 2006)

A KEY PLAYER TREATMENT OF INFECTIOUS DISEASES: THE GROUP’S STRONG POINT Marbocyl ® , launched in 1995, is Vétoquinol’s most popular antibiotic and has a good market position. It is market leader in France, Spain, Great Britain, Ireland, Austria and second overall in Europe. The Marbocyl ® livestock range recorded very strong growth between 2005 and 2006. Vétoquinol is capitalising on its expertise in this field by developing different families of antibiotics, with protocols adapted for different species. This approach combines effective treatments and respect for the environment and the consumer. Aurizon ® , launched in 2001, is the market leader in Europe. This product is prescribed for bacterial and fungal otitis externa in dogs. TREATMENT OF PAIN AND INFLAMMATION Alleviating an animal’s pain is an ethical challenge which is very much in demand in our society nowadays where the animal’s well-being is more and more important. Vétoquinol is well represented in this sector with Tolfedine ® for dogs and cats (non-steroidal anti-inflammatory – NSAID) and Tolfine ® for livestock. Thanks to Tolfedine ® , indicated in the treatment of inflammatory or painful locomotor infections in dogs and cats, Vétoquinol is no. 2 or no. 3 in most European countries. CARDIOLOGY AND NEPHROLOGY TREATMENTS Cardiac and renal insufficiency are the most common chronic diseases affecting elderly dogs and cats. Vétoquinol has developed some innovative treatments in this fast-growing sector. In 2002, the group launched Prilium ® , a product for dogs with cardiac insufficiency, with an innovative galenic formulation (the only one to be marketed in a liquid form). As it is available in most European countries, Australia and New Zealand, there has been strong growth: +25% in 2006. The group stands out in the market due to its wide range of products such as Clavaseptin ® , Epakitin ® , Propalin ® and Zentonil ® . VÉTOQUINOL HAS DECIDED TO CONCENTRATE ON THREE STRONG AREAS WHERE ITS EXPERTISE WILL MAKE A DIFFERENCE“ HANS HOLLEGIEN GROUP DIRECTOR, STRATEGY AND CUSTOMER RELATIONS With Marbocyl ® , Aurizon ® , Tolfedine ® , Prilium ® and Clavaseptin ® , Vétoquinol has developed leading products which stand out through their innovation and practicality. ” 22 - 23 LEADING PRODUCTS